Menopause brings a laundry list of symptoms and changes to women’s lives, from hot flashes and sleep disruptions, to ...

The following is a summary of “Efficacy and safety of topical minocycline preparations for papulopustular rosacea: a systematic review and meta-analysis,” published in the April 2025 issue of ...

Struggling with rosacea? Get better results with fewer products! Simplify your skincare routine, reduce redness, and calm ...

How to calm rosacea and deal with rude comments about skin. How one writer got a diagnosis, and the treatments and lifestyle ...

Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

Patients with rosacea experienced improvement with Emrosi, an oral minocycline hydrochloride extended-release product, ...

Many products fail to address the root causes of redness. Revoderm Pharma takes a science-backed, dermatologist-developed ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...

Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month.The Irvine-based biopharmaceutical ...

New antibiotic has been approved for uncomplicated UTIs; Cabometyx approved for advanced neuroendocrine tumors; new rosacea treatment option; Tremfya ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...